Quantitative plaque analysis with PCCT could improve CAD assessment

Wednesday, December 2 | 3:00 p.m.- 4:00 p.m. | W7-SSCA08-3 | Room E353C

Quantitative plaque parameters derived from photon-counting CT (PCCT) show promise for predicting major adverse cardiovascular events (MACE).

A group of researchers led by presenter Mingxing Sun of the General Hospital of Ningxia Medical University in Yinchuan, China, conducted a study that included 286 patients who underwent PCCT coronary CT angiography between January 2024 and March 2025; patients had complete baseline clinical data, diagnostic image quality for quantitative plaque analysis, and outcome information from clinic visits or telephone follow-up. The study's primary endpoint was MACE (cardiovascular death, heart attack, hospitalization for unstable angina, or unplanned revascularization).

What did the team find? Of the total number of patients, 32 (11.2%) experienced a major adverse cardiovascular event during median follow up of 18 months. Higher lipid-rich plaque burden predicted MACE (adjusted hazard ratio, 2.41; p = 0.007).

"Quantitative plaque analysis with PCCT may improve individualized prognostic assessment in coronary artery disease," Sun and colleagues concluded.

 Check out this Wednesday session to learn more.

Page 1 of 2
Next Page